PDE8A Blocking Peptide for STJ502377 peptide (STJ504672)
SPECIFICATIONS
ImmunogenSynthetic cyclic peptide from near the N terminus common to all PDE8A variants.
General Information
| Short Description | PDE8A Blocking Peptide for STJ502377 is synthetically produced from the N-Term sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic cyclic peptide from near the N terminus common to all PDE8A variants. |
| Immunogen Region | N-Term |
| Specificity | This blocking peptide is recommended for use in combination with PDE8A antibody, STJ502377 |
Additional Info
| Background | Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in maintaining basal levels of the cyclic nucleotide and/or in the cAMP regulation of germ cell development. |
Information sourced from Uniprot.org